FDA Approves Schizophrenia Drug Cobenfy, the First in Decades
The US Food and Drug Administration (FDA) has approved the first schizophrenia treatment in decades. It was approved by announced On Thursday, CNBC reported on the Bristol-Myers Squibb drug known as Cobenfi. “Bristol-Myers Squibb Co. plans to launch a twice-daily pill sold under the brand name Cobenfy in late October, executives told CNBC.'' Some medical […]